Collegium Pharmaceutical, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $202.9M | $186.4M |
| FY2022 | — | $194.8M | $173.7M |
| FY2023 | — | $195.4M | $238.9M |
| FY2024 | — | $228.8M | $70.6M |
| FY2025 | — | $301.7M | $231.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $202.9M | $186.4M |
| FY2022 | — | $194.8M | $173.7M |
| FY2023 | — | $195.4M | $238.9M |
| FY2024 | — | $228.8M | $70.6M |
| FY2025 | — | $301.7M | $231.3M |